DK0656906T3 - Endothelcellemolekyle, der medierer lymfocytbinding i mennesket - Google Patents

Endothelcellemolekyle, der medierer lymfocytbinding i mennesket

Info

Publication number: DK0656906T3
Authority: DK; Denmark
Prior art keywords: man; vap; endothelial cell; cell molecule; lymphocyte binding
Prior art date: 1992-06-09

Application number

DK93913035T

Other languages

English (en)

Inventor

Sirpa Jalkanen

Marko Salmi

Original Assignee

Biotie Therapies Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-09

Filing date

1993-06-09

Publication date

1999-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25404388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0656906(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-06-09 Application filed by Biotie Therapies Oy filed Critical Biotie Therapies Oy

1999-12-20 Application granted granted Critical

1999-12-20 Publication of DK0656906T3 publication Critical patent/DK0656906T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Toxicology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Mycology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

DK93913035T 1992-06-09 1993-06-09 Endothelcellemolekyle, der medierer lymfocytbinding i mennesket DK0656906T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US89535492A	1992-06-09	1992-06-09
PCT/FI1993/000250 WO1993025582A1 (en)	1992-06-09	1993-06-09	A novel endothelial cell molecule mediating lymphocyte binding in man

Publications (1)

Publication Number	Publication Date
DK0656906T3 true DK0656906T3 (da)	1999-12-20

Family

ID=25404388

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93913035T DK0656906T3 (da)	1992-06-09	1993-06-09	Endothelcellemolekyle, der medierer lymfocytbinding i mennesket

Country Status (14)

Country	Link
EP (1)	EP0656906B1 (da)
JP (2)	JP3431922B2 (da)
KR (1)	KR100268772B1 (da)
AT (1)	ATE184315T1 (da)
AU (1)	AU671837B2 (da)
CA (1)	CA2137551C (da)
DE (1)	DE69326347T2 (da)
DK (1)	DK0656906T3 (da)
ES (1)	ES2135480T3 (da)
FI (1)	FI121176B (da)
GR (1)	GR3031255T3 (da)
HU (1)	HU217175B (da)
NZ (2)	NZ253151A (da)
WO (1)	WO1993025582A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0002234A3 (en) *	1997-05-23	2005-11-28	Biotie Therapies Ltd	Vascular adhesion protein-1 having oxidase activity
FI20020807A0 (fi) *	2002-04-29	2002-04-29	Biotie Therapies Oyj	Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
FI20061156A0 (fi)	2006-12-27	2006-12-27	Elina Kivi	Uusia peptidejä
FI20075278A0 (fi)	2007-04-20	2007-04-20	Biotie Therapies Corp	Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995000658A1 (en) *	1993-06-18	1995-01-05	Sirpa Jalkanen	COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6

1993
- 1993-06-09 AT AT93913035T patent/ATE184315T1/de active
- 1993-06-09 AU AU43281/93A patent/AU671837B2/en not_active Expired
- 1993-06-09 EP EP93913035A patent/EP0656906B1/en not_active Expired - Lifetime
- 1993-06-09 JP JP50115594A patent/JP3431922B2/ja not_active Expired - Lifetime
- 1993-06-09 WO PCT/FI1993/000250 patent/WO1993025582A1/en not_active Ceased
- 1993-06-09 NZ NZ253151A patent/NZ253151A/en not_active IP Right Cessation
- 1993-06-09 KR KR1019940704502A patent/KR100268772B1/ko not_active Expired - Lifetime
- 1993-06-09 DK DK93913035T patent/DK0656906T3/da active
- 1993-06-09 DE DE69326347T patent/DE69326347T2/de not_active Expired - Lifetime
- 1993-06-09 NZ NZ299958A patent/NZ299958A/en not_active IP Right Cessation
- 1993-06-09 CA CA002137551A patent/CA2137551C/en not_active Expired - Lifetime
- 1993-06-09 ES ES93913035T patent/ES2135480T3/es not_active Expired - Lifetime
- 1993-06-09 HU HU9403516A patent/HU217175B/hu unknown
1999
- 1999-09-20 GR GR990402349T patent/GR3031255T3/el unknown
2002
- 2002-10-01 JP JP2002289280A patent/JP3500384B2/ja not_active Expired - Lifetime
2009
- 2009-03-16 FI FI20095269A patent/FI121176B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2137551C (en)	2002-03-26
WO1993025582A1 (en)	1993-12-23
FI20095269L (fi)	2009-03-16
KR950701938A (ko)	1995-05-17
JP2003180346A (ja)	2003-07-02
HU9403516D0 (en)	1995-02-28
EP0656906A1 (en)	1995-06-14
JP3500384B2 (ja)	2004-02-23
HU217175B (hu)	1999-12-28
CA2137551A1 (en)	1993-12-23
NZ299958A (en)	2000-07-28
JPH07507557A (ja)	1995-08-24
NZ253151A (en)	1997-03-24
ATE184315T1 (de)	1999-09-15
AU4328193A (en)	1994-01-04
HUT75824A (en)	1997-05-28
AU671837B2 (en)	1996-09-12
ES2135480T3 (es)	1999-11-01
DE69326347D1 (de)	1999-10-14
JP3431922B2 (ja)	2003-07-28
KR100268772B1 (ko)	2000-10-16
EP0656906B1 (en)	1999-09-08
GR3031255T3 (en)	1999-12-31
FI121176B (fi)	2010-08-13
DE69326347T2 (de)	2000-02-24

Similar Documents

Publication	Publication Date	Title
DE69429095D1 (de)	2001-12-20	Humanisierte antikoerper
ES2106195T3 (es)	1997-11-01	Anticuerpo igg aglicosilado anti cd3.
DK0724456T3 (da)	2004-04-13	CD40-Antistoffer
ATE218387T1 (de)	2002-06-15	Antikörperreinigung
DE60231651D1 (de)	2009-04-30	Proteinreinigungsverfahren
DK0673255T3 (da)	2001-12-10	Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
UA29494C2 (uk)	2000-11-15	Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DE69531679D1 (de)	2003-10-09	Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
ES2173130T3 (es)	2002-10-16	Metodo de fijacion de material al peptido beta-amiloide.
NO20083805L (no)	2002-10-22	Anvendelse av et antistoff som binder Aβ-peptidsekvenser
MY154009A (en)	2015-04-30	Anti-alpha v beta 6 antibodies
DE69233735D1 (de)	2008-07-17	Bindungsdomänen des Delta-proteins
KR950700779A (ko)	1995-02-20	단백질의 정제방법(Protein purification)
FI100973B (fi)	1998-03-31	Menetelmä antigeenirakenteiden valmistamiseksi "Major Histocompatibili ty Complex" (MHC) luokka I -antigeeneistä ja monoklonaalisista vasta-a ineista
NO942912L (no)	1994-10-06	Konstruksjon, kloning og ekspresjon av humaniserte, monoklonale antistoffer mot humant interleukin-5
DE69028513D1 (de)	1996-10-17	Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
MX9704897A (es)	1998-06-28	Secuencias del anticuerpo anti-idiotipo monoclonal recombinante 3h1 relacionadas con el antigeno carcinoembrionico humano.
DE59107756D1 (de)	1996-06-05	Monoklonale Antikörper gegen Melanom
BG40318A3 (bg)	1986-11-14	Метод за получаване на имуноглобулинови производни на виндезина
EP1411962A4 (en)	2005-02-02	TREATMENT OF PANCREATIC CANCER WITH A MONOCLONAL ANTIBODY
DK407987D0 (da)	1987-08-05	Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DK0840620T3 (da)	2002-02-04	IL-8-antagonister til behandling af astma
DK0493446T3 (da)	1997-08-11	Behandling af autoimmunsygdom.
DK0656906T3 (da)	1999-12-20	Endothelcellemolekyle, der medierer lymfocytbinding i mennesket
DK0501215T3 (da)	2000-09-18	Fusionsproteiner indeholdende monoklonalt antistof, linker og beta-glucuronidase til pro-drug-aktivering, deres fremstillin